Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • The clinical and cost-effectiv...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation

The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation

Bibliographic Details
Main Authors: A Pandor, S Eggington, S Paisley, P Tappenden, P Sutcliffe
Format: Article
Language:English
Published: NIHR Journals Library 2006-11-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta10410
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.3310/hta10410

Similar Items

  • Economic comparison of capecitabine + oxaliplatin and 5-fluorouracil + oxaliplatin in the adjuvant treatment of colon cancer
    by: Colombo GL., et al.
    Published: (2012-03-01)
  • The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation
    by: D Hind, et al.
    Published: (2008-05-01)
  • Adjuvant 5‐Fluorouracil/leucovorin, capecitabine, and oxaliplatin‐related regimens for stage II/III colon cancer patients 66 years or older
    by: Emily Jones, et al.
    Published: (2023-02-01)
  • Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer.
    by: Jingyuan Peng, et al.
    Published: (2018-01-01)
  • Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer
    by: P Tappenden, et al.
    Published: (2007-03-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs